Acrivon Therapeutics, Inc. Common Stock
- ACRV
- NASDAQ
- Biotechnology
- Precision Oncology
- Proteomics-Based Diagnostics
$1.64
Today −6.82%Quote Oct 16, 2026, 08:00 PM UTC
−3.53%over the last month
Max drawdown −23.7%From 1-month high −23.7%3 months −5.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$70.3M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$21.83
+1231.1% from here
Floor
$1.63
0.6% below price
Where the price sits
10 analysts
Analyst range, low to high
$17.00$30.00
- Price $1.64
- Resistance $1.69
- Consensus $21.83
The price is just above its floor and right under resistance. Analysts' average target sits about 1231% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ACRVPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
75